In particular, no impact on survival was seen when NRAS mutations were measured in primary disease 26, 27, however when measured from metastases, NRAS mutations were associated with improved survival compared to tumours with BRAF mutations or TWT tumours 28, 29. The gene discussed is BRAF; the disease is neoplasm.